Cardinal Health extends CVS deal through 2032: what it means for Cardinal Health stock

Published on 10/15/2026 at 10:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health reaffirmed fiscal 2027 EPS guidance at USD 12.40-12.60. Cardinal Health stock trades at EUR 222.00 on October 15, 2026.

Contract and earnings calendar

Cardinal Health extended its CVS Health distribution agreements through June 30, 2032, on October 1, 2026.
Fiscal 2027 adjusted earnings per share guidance stands at USD 12.40-12.60, according to Cardinal Health on October 1, 2026.
Cardinal Health stock traded at EUR 222.00 at 9:46 a.m. CEST at Lang & Schwarz on October 15, 2026.

Geometrisches Bauhaus-Poster mit Text PHARMA DISTRIBUTION in Rot und Schwarz — Bauhaus-Poster für Cardinal Health Inc. zeigt geometrische Pharma-Distribution-Grafik – NYSE ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) was trading at EUR 222.00 at Lang & Schwarz on October 15, 2026, at 9:46 a.m. CEST. The company had extended its pharmaceutical distribution agreements with CVS Health through June 30, 2032, and reaffirmed its fiscal 2027 adjusted earnings per share guidance on October 1, 2026, according to Cardinal Health.

CVS agreement adds visibility

The binding letter of intent keeps the existing scope of distribution services in place through June 30, 2032. The agreement therefore extends a major customer relationship, but the company disclosed no financial terms or change in service scope.

The SEC filing identifies Cardinal Health's common shares as trading under ticker CAH on the New York Stock Exchange and dates the agreement announcement to October 1, 2026.

What does the renewal mean for earnings?

The immediate earnings signal is guidance rather than a new profit forecast. Cardinal Health reaffirmed fiscal 2027 non-GAAP earnings per share of USD 12.40-12.60, equivalent to growth of 13 to 15 percent based on adjusted fiscal 2026 results that exclude an IEEPA tariff refund, according to Cardinal Health. The company also maintained its long-term non-GAAP earnings per share growth guidance at 12 to 14 percent.

Three dates frame the stock

On August 11, 2026, Cardinal Health reported quarterly adjusted earnings per share of USD 2.91 against a USD 2.42 consensus estimate, while revenue rose 5.80 percent year over year to USD 63.67 billion, according to MarketBeat. On October 1, 2026, it announced the CVS extension and repeated its fiscal 2027 guidance. On October 15, 2026, the euro-denominated stock indication stood at EUR 222.00.

Upcoming dates for investors

Cardinal Health plans to release fiscal 2027 first-quarter results on November 5, 2026, before trading opens in New York, with a webcast at 8:30 a.m. Eastern time, according to Cardinal Health. The renewed CVS arrangement runs through June 30, 2032.

Stock price and market context

Cardinal Health had a market capitalization of USD 57.4 billion and a 52-week range of USD 152.46 to USD 258.30 as of October 14, 2026. The stock was trading at EUR 222.00 at Lang & Schwarz on October 15, 2026, at 9:46 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.